Anterogen.Co.Ltd (065660) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩281.98 Million ≈ $191.09K USD) by net assets (₩90.04 Billion ≈ $61.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Anterogen.Co.Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Anterogen.Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anterogen.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anterogen.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tenaya Therapeutics Inc NASDAQ:TNYA	-0.188x
Hanmiglobal KO:053690	-0.005x
Sarana Mitra Luas JK:SMIL	0.105x
Superkrane Mitra Utama Tbk PT JK:SKRN	0.091x
P2 Gold Inc V:PGLD	-0.511x
SR Bancorp, Inc. Common stock NASDAQ:SRBK	0.019x
Hwashin Precision Engineering Co. Ltd KQ:126640	-0.060x
Stomil Sanok SA WAR:SNK	0.074x

Annual Cash Flow Conversion Efficiency for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 065660 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩110.21 Billion ≈ $74.69 Million	₩-860.38 Million ≈ $-583.06K	-0.008x	+49.17%
2023-12-31	₩129.44 Billion ≈ $87.72 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.015x	+16.96%
2022-12-31	₩106.79 Billion ≈ $72.37 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.018x	+29.02%
2021-12-31	₩116.87 Billion ≈ $79.20 Million	₩-3.05 Billion ≈ $-2.06 Million	-0.026x	+52.15%
2020-12-31	₩81.07 Billion ≈ $54.94 Million	₩-4.41 Billion ≈ $-2.99 Million	-0.054x	-125.90%
2019-12-31	₩68.39 Billion ≈ $46.35 Million	₩-1.65 Billion ≈ $-1.12 Million	-0.024x	+10.16%
2018-12-31	₩56.07 Billion ≈ $38.00 Million	₩-1.50 Billion ≈ $-1.02 Million	-0.027x	-429.83%
2017-12-31	₩46.61 Billion ≈ $31.58 Million	₩379.21 Million ≈ $256.98K	0.008x	+311.89%
2016-12-31	₩34.02 Billion ≈ $23.06 Million	₩-130.65 Million ≈ $-88.54K	-0.004x	-107.57%
2015-12-31	₩16.64 Billion ≈ $11.28 Million	₩844.49 Million ≈ $572.30K	0.051x	+165.11%
2014-12-31	₩12.96 Billion ≈ $8.78 Million	₩-1.01 Billion ≈ $-684.63K	-0.078x	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$136.64 Million

₩201.62 Billion KRW

Market Cap Rank

#18081 Global

#800 in Korea

Share Price

₩25350.00

Change (1 day)

-5.76%

52-Week Range

₩20350.00 - ₩58000.00

All Time High

₩197700.00